An update on renoprotective and nephrotoxicity of statins

Azar Baradaran, Zahra Hasanpour, Mahmoud Rafieian-Kopaei

Abstract


Abstract

Statins are employed in the treatment of hyperlipidemia. Their main mechanism of action is inhibition of HMG-reductase, however, they have various other effects independent of their cholesterol lowering mechanism. These include anti-inflammatory and anti-oxidant properties. Statins can reduce acute phase reactant. They inhibit vascular micro inflammation, enhancing endothelial cell function, inhibiting proliferation of vascular smooth muscle, reducing platelet activation and aggregation and increasing atherosclerotic plaque stability. Many of these effects are postulated to arise from disruption of small G-proteins. This is not clear whether statins are nephrotoxic or nephroprotective agents. There is not enough data about their effects on nephrons. Cardiologists and internists use statins widely in many conditions but there is evidences against their safety. Further studies are necessary to determine the biological mechanism of kidney injury
in statin users.

 

Core tip

There are various other effects independent of their cholesterol lowering
mechanism for statins. These include anti-inflammatory and anti-oxidant properties. Statins can diminish acute phase reactant. They inhibit vascular micro-inflammation, enhancing endothelial cell function, inhibiting proliferation of vascular smooth muscle, reducing platelet activation and aggregation and increasing atherosclerotic plaque stability.

 

Citation

Baradaran A, Hasanpour Z, Rafieian-Kopaei M. An update on renoprotective and nephrotoxicity of statins. Ann Res Antioxid. 2016;1(2):e16.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.



ISSN: 2476-5511



Publish Free - Access Free

 

A Publication of Society of Diabetic Nephropathy Prevention

 

Annals of Research in Antioxidants follows

 

http://publicationethics.org/resources/flowcharts

Publisher

This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 by Annals of Research in Antioxidants (ARA)\

Society of Diabetic Nephropathy Prevention